top of page

The Co-CEO of Renibus Therapeutics shares a company's perspective of the N. Texas biotech ecosystem

Jeff Keyser tells us about trying to help patients recover from surgeries more efficiently and the phase 2 data that led to Renibus' breakthrough therapy designation.



Brought to you by:



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page